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Conclusion.— Benﬂuorex-related valvulopathy shares numerous92
or age and gender, served as a control group. Clinical, plasma
T-proBNP, and valvulo-arterial impedence (Z) were also assessed.
esults.— When compared to controls, pts with AS had higher
aseline LAD ﬂow velocity (37± 10 vs. 28± 9 cm/s, P < 0.05), sim-
lar hyperemic LAD ﬂow velocity (84 20 vs. 85± 21, P =NS), and
onsequently lower CFR (2.35± 0.68 vs. 3.2± 0.8, P < 0.01). In
ts with AS, there was a signiﬁcant inverse correlation between
FR and age (r =−0.33), E/Ea (early diastolic transmitral ﬂow
elocity/early diastolic mitral tissue Doppler annular velocity), LV
ass/m2, NT-proBNP (r =−0.45), pulmonary artery systolic pressure
PASP), baseline LV rate-pressure product (LVPP) [(mean gradi-
nt + systolic blood pressure)× heart rate)], heart rate, and left
trial volume/m2 (LAV) (all, P < 0.05), and a signiﬁcant positive cor-
elation between CFR and LVEF, and deceleration time of E (all,
< 0.05). The correlation between CFR and Z was of borderline sig-
iﬁcance. Furthermore, compared to asymptomatic AS pts (n = 10),
ymptomatic AS pts had a more severely impaired CFR (2.2± 0.6 vs.
.76± 0.8, P < 0.05), higher baseline and lower hyperemic LAD ﬂow
elocities (all, P < 0.05), and higher NT-proBNP values (P = 0.01).
n multivariate analysis, after adjusting for AS severity, NT-proBNP
as the main independent predictor of CFR (P < 0.01), and among
chographic variables, PASP and LVPP (all, P < 0.01). PASP was inde-
endently predicted by age, DTE and LAV (all, P≤ 0.01).
onclusion.— In patients with severe AS and preserved LVEF, there is
relatively wide range of CFR values. CFR is more severely impaired
n symptomatic AS pts and is mainly determined by increased LV wall
tress and workload, and diastolic dysfunction.
oi:10.1016/j.acvd.2011.03.069
chocardiographic predictors of mitral regurgitation following
ercutaneous balloon mitral valvulotomy
. Saaidi , K. Selmi , A. Mokaddem , M.-R. Boujnah
Hopital Mongi Slim, La Marsa, Tunisia
ntroduction.— Percutaneous balloon mitral valvulotomy (PBMV) in
heumatic mitral stenosis is effective. However, complications such
s severe mitral regurgitation (MR) may occur. Therefore, it is jus-
iﬁed to predict the occurrence of this complication.
bjectives.— This study was undertaken to evaluate the morphology
f the mitral valve and the subvalvular apparatus as assessed by
chocardiography and its role in predicting the occurrence of MR
fter PBMV with the Inoue balloon.
ethods.— Three hundred and thirty patients who underwent 356
BMV were evaluated retrospectively. MR occurred in 22 proce-
ures (6.1%). We have compared the 22 patients who developed
R to 128 patients without MR or with mild to moderate MR. The
orphology of the mitral apparatus on the baseline echograms
as assessed: valvular mobility, thickening and calciﬁcation, com-
issural morphology, subvalvular thickening and heterogeneity of
esions distribution. Both Wilkins and Padial scores were calculated.
esults.— Echocardiographic predictors of severe MR were grade 2
R (odds ratio = 6), Wilkins score (9,8± 2,9 vs 8,1± 2,5; P = 0,004)
ith a cut-off point of 10 (odds-ratio = 3), Padial score (12± 1,6
s 8,8± 1,5; P < 0,001) with a cut-off point of 10 (odds-ratio = 28),
eterogeneity of lesions distribution in the anterior mitral leaﬂet
c
c
t19th International Congress of Echocardiography
odds-ratio = 17), commissural calciﬁcation (odds-ratio = 14) and
ubvalvular thickening (odds-ratio = 7). However, valvular mobility,
hickening and calciﬁcation were unable to predict severe MR. The
echanism of severe MR was valvular tear in the most thin zones as
ssessed on echocardiography.
onclusion.— Commissural calciﬁcation rather than valve calciﬁca-
ion and the heterogeneity of lesions distribution rather than their
everity are strong predictors of severe MR following PBMV. The
adial score based on these criteria has supplanted the Wilkins score
n predicting this complication.
oi:10.1016/j.acvd.2011.03.070
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aréchauxe, J.-C. Eicher f, B. Blanchard-Lemoineg, J. Rousseauh,
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im.— The aim of this study is to report clinical characteris-
ics, consequences, echocardiographic features, and pathological
ndings encountered in patients suffering from valvular disease
ssociated with benﬂuorex exposure in a multicentre French
egistry.
ethods.— Forty patients suffering from unexplained restrictive
alvular disease with a previous exposition to benﬂuorex, a fen-
uramine derivative, were identiﬁed from eight French university
ospitals.
esults.— Patients were mostly women (87.5%) with a mean age
f 57 + 9 years and high body mass index of 30 + 7 kg/m2; 37.5% of
hem presented with severe heart failure symptoms (NYHA class
II and IV). Benﬂuorex mean daily dose was 415 + 131mg with total
herapy duration of 72 + 53months. Resulting cumulative dose was
10 + 675 g. Common echocardiographic ﬁndings were leaﬂets and
ubvalvular apparatus thickening and retraction. Aortic and mitral
alve regurgitations resulting from leaﬂets loss of coaptation were
he most frequent ﬁndings (87.5 and 82.5%) and were severe in
9 patients (72.5%). Multiple valve involvements were present in
1 cases (77.5%). Pulmonary arterial hypertension was identiﬁed in
0 cases (50%). Histopathological examination demonstrated abun-
ant extracellular matrix encasing the leaﬂets without modiﬁcation
f valve architecture. Fifteen patients (37.5%) underwent valvular
urgery.haracteristics with other drug-induced valvular disease. Clinical
onsequences may be serious with severe heart failure symptoms
hat may lead to surgical treatment.
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Valvular disease associated with benﬂuorex: Prevalence and
echocardiographic features
A. Boudes , J.-F. Avierinos , A. Salem , C. Lavoute , Y. le Dolley , G.
Habib
La Timone, Marseille, France
Background and objectives.— Restrictive valvular heart disease has
recently been reported in patients after benﬂuorex exposure. How-
ever, little is known about its prevalence and echocardiographic
features. The aim of our study was to assess the prevalence of ben-
ﬂuorex exposure in patients with restrictive mitral or aortic valve
disease and to describe their echocardiographic characteristics.
Methods.— In a single center study, patients with a ﬁnal diagnosis of
unexplained restrictive aortic and/or mitral valvular disease were
studied. Only patients with at least moderate valvular regurgita-
tion were included. All echocardiographic records were analysed
by two experienced observers. Patients were interrogated for their
previous use of benﬂuorex or other appetit-suppressant drugs.
Results.— Sixty-eight consecutive patients, aged 58± 9 years, with
restrictive aortic and/or mitral valvular disease were studied,
including 63 (93%) women. Among them, 54 (82%) had had previ-
ous treatment with appetit-suppressant drugs, including benﬂuorex
alone in 19 (28%) patients, or in combination with another appetit-
suppressant drug, mainly dexfenﬂuramine, in the remaining cases.
Among patients with both mitral and aortic involvement, 39 (97%)
had been exposed to benﬂuorex, isolated (n = 14) or in combination
with another appetit-suppressant drug (n = 25). Echocardiographic
features included combined mitral and aortic regurgitation with
restricted valve motion in 40 (59%) cases, and isolated mitral or
aortic involvement in 5 and 12 patients, respectively.
Conclusion.— The prevalence of appetit-suppressant drugs expo-
sure is very high in patients with left heart restrictive valvular
regurgitation. Multiple drugs exposure is frequent in these patients.
Combined aortic and mitral restrictive valve regurgitation is highly
suggestive of valvulopathy associated with benﬂuorex or other
appetit-suppressant drug valve disease.
doi:10.1016/j.acvd.2011.03.072
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valuation of right ventricular function in patients with organic
itral regurgitation
. Deswartea, C. Vanessona, A.-S. Polgea, M. Richardsona, A.
incentelli a, P.-V. Ennezata, C. Bauters a, C. Foucherb, T. le
ourneauc
Hôpital cardiologique, Lille, France
Hôpital Salengro, Lille, France
Institut du thorax, Nantes, France
bjectives.— The aim of this study was to assess right ventricular
RV) ejection fraction (EF) and its determinants in patients with
rganic mitral regurgitation (MR) by radionuclide angiography.
ethods.— Two-hundred eight patients (62± 13 years, 135 males)
ith moderate to severe organic MR underwent an echocardio-
raphic examination and left and right ventricular assessment by
adionuclide angiography. The left ventricle (LV) was divided into 9
egions to assess regional LV function.
esults.— Mean RV EF was 40± 10%, ranging from 10 to 65%.
ne hundred ﬁfty-one patients were in sinus rhythm, and 57
atients (27%) in atrial ﬁbrillation. Tricuspid annulus S wave
elocity measured in a subset of patients (n = 92) correlated
eakly with RV EF (r = 0.27, P = 0.018). Fifty-nine patients (28%)
ad a RV EF < 35%. Patients with RV EF < 35% had lower systolic
lood pressure (P = 0.045), larger RV (P = 0.007), higher pulmonary
rtery systolic pressure (PASP, P = 0.045) and had more diuretics
P = 0.009) compared with those with RV EF > 35%. In univariate
nalysis, echocardiographic predictors of RVEF were LVEF (r = 0.33,
< 0.0001), LV end-diastolic diameter (r =−0.26, P = 0.001) and vol-
me (r =−0.29, P = 0.001), left atrial size (r =−0.22, P = 0.003),
itral E velocity (r =−0.29, P < 0.0001), PASP (r =−0.22, P = 0.004),
nd aortic stroke volume (r = 0.31, P = 0.007). In the subset of
atients with effective regurgitant oriﬁce (ERO) and regurgitant vol-
me quantiﬁcation RV EF correlated with ERO (r =−0.34, P = 0.005)
nd regurgitant volume (r =−0.33, P = 0.008). RV EF correlated
losely with radionuclide LV septal function (regional LV EF 8:
= 0.49, P < 0.0001). In multivariate analysis, LV septal function
r = 0.43, P < 0.0001) was the main determinant of RV function. LV
nd-diastolic diameter (r =−0.25, P < 0.0001) and PASP (r =−0.18,
= 0.009) were also independent predictors of RVEF.
